Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus.
Cyclosporine is widely known to be effective in cases involving both transplantation as well as a spectrum of immune-mediated diseases, although careful monitoring is required for the preemptive detection of its adverse effects. Here we report the successful treatment by extremely low dose cyclosporine (1 mg/kg per day) of two patients with thrombocytopenia in systemic lupus erythematosus.
Sugiyama
M
M
Department of Medicine, Juntendo University Izu-Nagaoka Hospital, Shizuoka, Japan.
Ogasawara
H
H
Kaneko
H
H
Hishikawa
T
T
Sekigawa
I
I
Iida
N
N
Hashimoto
H
H
Hirose
S
S
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D016572:Cyclosporine